End-to-End Clinical Trial & CRO Services in Spain
Advancing Life Sciences Through Quality-Driven GxP Solutions
Spain is a leading European destination for pharmaceutical development and clinical research, supported by a robust healthcare infrastructure and experienced institutions. The Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) regulates medicines and clinical investigations, adhering to EU regulatory frameworks, including European Medicines Agency (EMA) guidelines, International Council for Harmonisation (ICH) standards, and Good Clinical Practice (GCP) principles. Clinical trials in Spain comply with ICH E6(R3) and the EU Clinical Trials Regulation (CTR 536/2014).
Spain’s robust clinical research environment and efficient regulatory pathways make it an attractive hub for product development in Europe. The country draws investment in advanced therapies and innovative technologies, supported by a collaborative network of stakeholders. Zenovel offers regulatory and quality solutions to assist healthcare organizations in meeting AEMPS requirements and achieving GxP compliance, facilitating the entire product lifecycle from development to post-approval activities.
Good Clinical Practice (GCP) in Spain for Regulatory Compliance and Clinical Excellence
Advancing Clinical Research Quality through GCP Compliance in Spain
Spain is a leading destination for clinical research in Europe, thanks to its strong healthcare infrastructure, skilled investigators, and effective regulatory framework. Clinical trials are regulated by the Spanish Agency of Medicines and Medical Devices (AEMPS) and must adhere to EU Clinical Trial Regulations and ICH-GCP standards. Zenovel offers customized Good Clinical Practice (GCP) CRO services to assist sponsors, CROs, and research sites in maintaining compliance and ensuring study quality and participant welfare.
Our GCP services in Spain include the following:
- GCP Quality and Compliance Consulting: We help organizations enhance clinical quality systems, optimize trial processes, and ensure compliance with GCP requirements throughout all phases of clinical development.
- ICH-GCP and European Regulatory Compliance Support: Experts offer guidance on compliance with ICH-GCP guidelines, EU Clinical Trial Regulation (EU CTR 536/2014), AEMPS requirements, and ethical standards for clinical research in Spain.
- Inspection Readiness and Quality Assurance: We assist sponsors and sites with mock inspections, quality assessments, documentation reviews, CAPA management, and compliance evaluations to prepare for regulatory inspections and audits.
- Sponsor Oversight and Vendor Management: Our team helps establish effective oversight frameworks for CROs, vendors, and clinical sites, ensuring accountability, quality control, and regulatory compliance throughout the study lifecycle.
- Risk-Based Quality Management and Monitoring: We implement risk-based approaches to monitoring and quality management that focus on critical data and processes, helping improve patient safety, data reliability, and overall trial performance.
Zenovel aids CROs in Spain by providing GCP solutions that enhance operational efficiency and ensure compliance with regulatory standards. Our services are designed to improve inspection readiness and support the successful execution of clinical trials in line with international and European standards.
Computer System Validation (CSV) Services in Spain for GCP, GxP & Data Integrity Compliance
Ensuring Regulatory Compliance and Reliable Clinical Systems Across Spain
Spain serves as a major center for clinical research and pharmaceutical innovation, necessitating validated computerized systems for data integrity and patient safety. Zenovel provides extensive Computer System Validation (CSV) services to pharmaceutical and healthcare stakeholders, aligning with GAMP 5, ICH-GCP, EU regulations, and AEMPS standards to support compliance and operational efficiency.
- Validation Strategy and Master Planning: Development of risk-based validation strategies, validation master plans (VMPs), and compliance roadmaps that align with organizational and regulatory requirements.
- User Requirements and Traceability Management: Review and refine User Requirements Specifications (URS), functional specifications, and requirements traceability matrices to ensure comprehensive validation coverage.
- Risk Assessment and System Classification: Comprehensive risk assessments identify critical system functions, data integrity risks, and validation priorities following GAMP 5 methodologies.
- IQ, OQ, and PQ Testing Support: Execution and documentation of Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) ensure the system is fit for its intended use.
- Data Integrity and Audit Trail Evaluation: Assessment focuses on audit trails, user access controls, data governance, and electronic records management to ensure compliance with regulatory standards.
- Electronic Records and Electronic Signatures Compliance: Support for adherence to EU Annex 11 and 21 CFR Part 11 regulations, as well as requirements for electronic records and signatures.
- Change Management and Ongoing Compliance: Support for processes related to change control, system upgrades, periodic reviews, deviation management, and retirement planning is essential to maintain validated status throughout the system lifecycle.
- Validation Lifecycle Documentation: Preparation and maintenance of validation documentation entails creating and reviewing protocols, reports, SOPs, and validation packages.
Zenovel assists organizations in Spain in creating and maintaining validated computerized environments that ensure reliable clinical data and regulatory compliance. Our CSV experts collaborate with sponsors, CROs, and healthcare entities to reduce compliance risks and enhance inspection readiness. By combining validation practices with data integrity principles, Zenovel helps meet AEMPS, EU, and international GxP standards, supporting clinical research and healthcare programs.
GCP Audit Services in Spain for Clinical Trial Quality and Regulatory Compliance
Enhancing Clinical Research Quality through Independent GCP Audits in Spain
Robust quality oversight is essential for clinical trials and participant protection. Zenovel offers comprehensive GCP audit services in Spain, aiding sponsors, CROs, investigator sites, and vendors in regulatory compliance. Our independent audits identify quality risks, enhance oversight, and foster continuous improvement. Conducted under ICH E6(R3) GCP guidelines and EU regulations, audits comply with the Spanish Agency of Medicines and Medical Devices (AEMPS) standards.
Our GCP audit services includes:
- Clinical site audits are thorough evaluations of investigator sites, focusing on protocol adherence, participant safety, informed consent processes, source documentation, and general study management.
- Sponsors and CROs audit: Independent reviews of sponsor and CRO quality systems, operational processes, governance structures, and oversight activities are essential to ensure effective trial management and compliance with regulatory standards.
- Vendor and service provider audits: involve the evaluation of laboratories, technology providers, central service vendors, and other third-party partners in clinical research to ensure adherence to quality standards and compliance with contractual obligations.
- Quality Management System (QMS) assessments: involve detailed reviews of quality systems, SOPs, training records, deviation management processes, and quality governance frameworks.
- Regulatory and GCP Compliance Reviews: Assessment of compliance with ICH-GCP principles, EU Clinical Trial Regulation (EU CTR 536/2014), AEMPS expectations, and international standards in clinical research.
- Critical Quality and Data Integrity Evaluations: Focused audits covering protocol adherence, informed consent documentation, essential document management, source data verification, data integrity controls, and subject protection measures.
- CAPA Management and Inspection Readiness: Support for the development and implementation of CAPAs includes addressing audit findings, mitigating compliance risks, and preparing organizations for regulatory inspections and sponsor audits.
Organizations in Spain conducting clinical trials must implement robust quality assurance to ensure compliance and reliable results. Zenovel’s experienced GCP auditors provide practical recommendations to enhance clinical quality systems and operational excellence. Our audit methodology assists sponsors, CROs, and research institutions in improving compliance oversight, reducing regulatory risk, and preparing for inspections by regulatory bodies like AEMPS and other international agencies.
CRO Setup & Upgradation Services in Spain with GCP and Regulatory Compliance
Building High-Performance CRO Operations Aligned with Local and Global Clinical Research Standards
Spain is a leading destination for clinical research, aided by top healthcare institutions and a supportive regulatory environment. To establish or expand a Contract Research Organization (CRO) in Spain, a strategic focus on quality, operational excellence, and regulatory compliance is essential. Zenovel offers CRO setup and upgrade services to aid pharmaceutical, biotechnology, and academic organizations in building sustainable, inspection-ready infrastructures aligned with AEMPS, EU regulations, and ICH-GCP standards, with an eye towards CPHI China 2026.
New CRO Setup Services
Our end-to-end CRO establishment solutions include:
Clinical Operations and Organizational Design
Quality Management System (QMS) Development
SOP Development and Documentation Frameworks
Clinical Technology and System Implementation
Risk-Based Monitoring and Quality Oversight
Vendor Qualification and Governance
Clinical Quality and Compliance Programs
Data Integrity and Regulatory Compliance Frameworks
Workforce Development and Training
Existing CRO Upgradation Services
For established organizations seeking operational excellence and enhanced compliance, Zenovel offers targeted improvement initiatives, including:
GCP Gap Assessments and Remediation
Quality System Enhancement and Modernization
Sponsor Oversight and Governance Strengthening
Risk-Based Quality Management Implementation
Clinical Monitoring Optimization
Vendor Management and Outsourcing Excellence
CAPA System Improvement
Inspection Readiness and Compliance Support
Data Integrity and Computerized System Compliance
Regulatory Alignment and Operational Excellence
Zenovel aids organizations in maintaining compliance and enhancing clinical research operations. Our offerings include inspection readiness, TMF reviews, clinical process evaluations, quality metrics tracking, CAPA management, sponsor oversight, and strategic regulatory consulting. As Spain emerges as a leading European clinical research hub, Zenovel ensures CROs are compliant, inspection-ready, and competitive in regional and global markets.
PK-Stat Review Services in Spain for Reliable Clinical Data Evaluation
Ensuring Efficacy and Safety of Pharmaceutical Products by Comprehensive Data Analysis Services
Error-free pharmacokinetic (PK) and statistical analysis are crucial for reliable clinical evidence and regulatory submissions. Zenovel offers PK-Stat Review Services in Spain for pharmaceutical, biotechnology, and healthcare organizations, emphasizing high-quality evaluation of clinical data during drug development. Our services enhance data integrity, scientific robustness, and regulatory compliance with AEMPS, EMA, ICH, and other international standards.
Our PK-Stat Review Services in Spain Include:
- PK/PD Analysis – Non-compartmental analysis (NCA), population PK modeling, exposure-response assessment, and dose-response evaluation.
- Regulatory Alignment – Compliance with AEMPS requirements, EMA guidelines, ICH standards, and other global regulatory frameworks.
- Data Integrity & Statistical Review – Clinical biostatistics review, statistical validation, data quality assessment, and preparation of submission-ready outputs.
- Regulatory Submission Support – Independent review for bioequivalence studies, clinical trials, marketing authorization applications, and lifecycle submissions.
Zenovel offers comprehensive PK analysis services, including bioavailability assessment, dose proportionality evaluation, PK/PD interpretation, population modeling, and statistical reporting in accordance with global regulatory standards. These services enhance data quality, minimize regulatory risks, and bolster confidence in clinical decisions.
By providing precise and defensible analyses, Zenovel facilitates successful regulatory interactions and improves the reliability of clinical development programs in Spain, Europe, and worldwide.
Pre-Inspection Readiness Services in Spain for GCP Compliance
Building Inspection Confidence Through Proactive GCP Readiness
Regulatory inspections are crucial for assessing the quality and compliance of clinical trials. Zenovel offers Pre-Inspection Readiness Services in Spain, aiding sponsors, CROs, and clinical research organizations in preparing for these inspections. The focus is on identifying compliance gaps and enhancing quality systems to ensure operational readiness. Using a risk-based approach, Zenovel evaluates clinical trial documentation, oversight activities, vendor management, quality management systems, and CAPA effectiveness to promote successful inspection outcomes and maintain regulatory compliance.
Zenovel performs readiness assessments and simulated regulatory inspections based on national and international regulatory standards, enabling organizations to recognize potential inspection issues, evaluate compliance maturity, and take corrective actions prior to formal inspections.
Our services include:
Clinical Trial Documentation and Quality System Reviews: Our experts conduct thorough reviews of trial documentation, informed consent processes, compliance with protocols, Trial Master File management, data integrity controls, safety reporting, vendor oversight, and quality management systems to ensure documentation is complete, accurate, and ready for inspection.
CAPA Evaluation and Remediation Planning: Effective CAPAs are crucial for establishing a strong quality culture and include Our adequacy, sustainability, effectiveness in root-cause investigation, and compliance with regulations, alongside practical strategies to remediate identified gaps.
Sponsor Oversight and Vendor Management Reviews: Zenovel evaluates oversight frameworks, governance, vendor qualification processes, risk management programs, and performance monitoring systems to ensure compliance with regulatory expectations and Good Clinical Practice requirements.
Inspection Preparedness Training and Interview Coaching: We offer specialized training programs for sponsors and study teams aimed at improving inspection preparedness. The training covers inspection management strategies, regulatory interaction, documentation readiness, and interview coaching to ensure confident responses during inspections.
Regulatory Alignment and Compliance Support: Our pre-inspection readiness services are aligned with the requirements of the AEMPS, ICH E6(R3) GCP guidelines, EU CTR 536/2014, EMA expectations, and other applicable international regulatory standards.
Zenovel’s inspection readiness specialists assist sponsors and CROs in creating compliance frameworks to ensure successful inspections and high-quality clinical research. By addressing compliance gaps and enhancing operational processes, we help organizations improve inspection outcomes and maintain confidence in Our clinical development programs.
Risk‑Based Monitoring (RBM) Services for Efficient Clinical Trials in Brazil
We ensure your clinical trial excellence in Brazil by our robust risk-based monitoring
Efficient clinical trial oversight is essential for data integrity, patient safety, and ANVISA compliance. Our risk‑based monitoring (RBM) services in Brazil optimize trial performance, reduce operational burden, and improve decision‑making.
Zenovel provides expert RBM services in Brazil:
- Proactive, data‑driven risk identification
- Centralized & remote monitoring capabilities
- GCP‑compliant RBM strategies for sponsor oversight
- Real‑time data review & site performance assessment
We help organizations detect deviations early, allocate resources smarter, and enhance trial visibility while maintaining full regulatory alignment.
Improve clinical trial efficiency with smarter, risk‑based monitoring in Brazil.
Sponsor Oversight Services in Spain for Clinical Trial Governance and Compliance
Strengthening Clinical Trial Oversight Through Effective Governance and Risk Management
Successful clinical trials require robust sponsor oversight to ensure regulatory compliance, patient safety, and data quality. Zenovel offers Sponsor Oversight Services in Spain to help sponsors maintain control over clinical operations and ensure adherence to regulatory standards throughout the study lifecycle.
Our Sponsor Oversight Services in Spain Include:
- CRO and Vendor Management: Oversight of CROs, laboratories, technology providers, and other vendors involves conducting performance reviews, qualification assessments, and compliance monitoring.
- Clinical Governance and Oversight Frameworks: Risk-based oversight models are being developed and implemented to enhance study management and ensure regulatory compliance.
- Site Performance Evaluation: Monitoring of site performance indicators, patient recruitment, protocol adherence, data quality, and operational efficiency.
- Quality and Compliance Monitoring: Review of quality metrics, CAPA effectiveness, audit outcomes, and compliance activities to strengthen trial quality and inspection readiness.
- Risk Management and Mitigation: Identification, assessment, and management of operational, quality, and regulatory risks throughout the clinical development process.
- Regulatory Compliance Support: Alignment with the requirements of the AEMPS, ICH E6(R3) guidelines, EU Clinical Trial Regulation, and international GCP standards.
Zenovel enhances clinical trial oversight and transparency with a proactive, risk-based approach, supporting better decision-making, vendor governance, study quality, and compliance with regulatory standards in Spain, Europe, and globally.
Good Manufacturing Practice (GMP) Services in Spain for Pharmaceutical Compliance
Supporting Regulatory Compliance and Manufacturing Excellence in Spain
Maintaining robust manufacturing standards is crucial for product quality, patient safety, and regulatory compliance in the pharmaceutical lifecycle. Zenovel offers GMP Services in Spain to assist organizations in establishing and enhancing compliant manufacturing operations. Our solutions aim to strengthen quality systems, improve operational performance, and ensure adherence to the Spanish Agency of Medicines and Medical Devices (AEMPS), EU-GMP guidelines, PIC/S GMP standards, and WHO GMP principles.
Our GMP Services in Spain Include:
- GMP Audits and Quality System Assessments
Comprehensive evaluations of manufacturing operations and QMS to identify compliance gaps and opportunities for continuous improvement. - Quality Management System Enhancement
Support for the development, implementation, and optimization of quality systems, procedures, and compliance frameworks. - Deviation Management and CAPA Support
Assessment and improvement of deviation handling, root cause analysis, CAPA, and documentation practices. - Inspection Readiness Programs: Gap assessments, mock inspections, remediation planning, and preparedness support to help organizations successfully navigate regulatory inspections and audits.
- Process Validation and GMP Consulting: Guidance on process validation, manufacturing controls, quality risk management, and sustainable GMP compliance practices.
- Documentation and Compliance Management: Review and enhancement of SOPs, batch records, validation documentation, quality records, and controlled document systems.
- Regulatory Compliance Alignment: Support for compliance with AEMPS requirements, EU-GMP regulations, PIC/S GMP standards, WHO GMP guidelines, and other applicable international quality frameworks.
Zenovel aids organizations in enhancing manufacturing quality and compliance oversight while ensuring inspection readiness through risk-based GMP solutions. Collaborating with manufacturers, Zenovel aims to establish robust quality systems, improve operational efficiency, and facilitate successful regulatory outcomes in Spain, Europe, and global markets.
GMP Audit Services in Spain for Manufacturing Quality Excellence
Enhancing Manufacturing Compliance Through Independent GMP Audits
Maintaining compliance with GMP is crucial for healthcare manufacturers in Spain. Zenovel offers GMP audit services to assess manufacturing systems, quality processes, and adherence to regulatory standards. Our approach aids organizations in identifying compliance risks, enhancing quality management systems, and improving readiness for inspections while fostering a culture of continuous quality improvement.
Our GMP audit services in Spain include:
- Facility and Quality System Audits: GMP audits provide a thorough evaluation of manufacturing facilities and quality management systems, assessing production processes, validation programs, deviation management, change control, CAPA effectiveness, and batch record review to ensure compliance with quality and regulatory standards.
- Supplier Qualification and Vendor Audits: Zenovel audits suppliers and contract manufacturers to evaluate vendor qualifications, quality agreements, risk management, GMP compliance, and supply chain oversight.
- Quality Risk Management Assessments: We conduct risk-based evaluations to identify compliance gaps, quality vulnerabilities, and operational risks, providing recommendations for effective corrective and preventive actions aligned with regulatory expectations.
- Inspection Readiness and Mock Audits: Zenovel offers services such as GMP gap assessments, mock inspections, interview preparedness sessions, and remediation planning to aid organizations in successfully managing inspections by regulatory authorities.
- Documentation and Data Integrity Reviews: Our reviewer team assesses document control systems, batch documentation, electronic records, audit trails, data governance practices, traceability, and adherence to ALCOA+ data integrity principles.
- Regulatory Compliance and GMP Alignment: Our GMP audits comply with the AEMPS, European GMP requirements, PIC/S GMP standards, ICH quality guidelines, WHO GMP principles, and other international regulatory frameworks, ensuring organizations meet local and global compliance standards.
Zenovel’s GMP auditors deliver objective, risk-based assessments to help organizations in the Spanish life sciences sector ensure compliance, enhance operational performance, and improve product quality throughout the manufacturing lifecycle, supporting sustainable compliance amidst evolving regulatory expectations.
Pharma Plant Setup & Upgradation Services in Spain for GMP Compliance
Building Future-Ready Pharmaceutical Manufacturing Facilities in Spain
Spain is a prominent pharmaceutical manufacturing hub in Europe, characterized by robust industrial infrastructure and a skilled workforce. Effective establishment or modernization of manufacturing facilities necessitates engineering expertise, quality systems, and regulatory compliance for market competitiveness.
Zenovel offers Pharma Plant Setup & Upgradation Services, assisting organizations in creating GMP-compliant facilities that align with the requirements of the Spanish Agency of Medicines and Medical Devices, EU-GMP standards, and global regulations.
Our Pharma Plant Setup & Upgradation Services in Spain Include
New Pharmaceutical Plant Setup: Our facility establishment services encompass all phases of pharmaceutical manufacturing infrastructure development.
Facility Planning and Engineering Design: Design includes manufacturing facilities, production areas, warehouse layouts, material and personnel flow systems, and architecture that complies with GMP.
Cleanroom Design and Qualification: Support is essential for cleanroom classification, environmental control strategies, qualification activities, and contamination prevention measures.
HVAC and Utility System Qualification: Design review, qualification, and validation of HVAC systems, purified water systems, compressed air systems, clean steam systems, and other critical utilities are essential processes to ensure functional reliability and compliance in various applications.
Equipment Qualification and Validation: Execution of Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) for manufacturing, packaging, laboratory, and utility equipment.
Quality Management System (QMS) Implementation: Development and implementation of GMP-compliant quality management systems involves establishing SOPs, quality policies, managing deviations, Corrective and Preventive Actions (CAPA), and change control processes.
Manufacturing Process Validation Support: Planning and execution of process validation activities ensure consistent product quality and compliance with regulatory standards.
Existing Plant Upgradation Services
For facilities seeking modernization, expansion, or compliance improvements, Zenovel provides customized upgrade solutions, including:
GMP Gap Assessment and Remediation: Comprehensive evaluation of facility operations, infrastructure, and quality systems identifies compliance gaps and develops effective remediation strategies.
Facility Modernization and Infrastructure Enhancement: Upgrades to production areas, utilities, cleanrooms, warehousing systems, and support infrastructure to improve operational efficiency and regulatory compliance.
Contamination Control Strategy Enhancement: Implementation of contemporary contamination control measures, environmental monitoring programs, and risk-based quality approaches in alignment with current GMP expectations.
Manufacturing Process Optimization: Improvement of production workflows, equipment utilization, operational efficiency, and manufacturing capacity to support business growth.
Capacity Expansion and Technology Integration: Support for facility expansion projects, technology transfers, automation initiatives, and digital transformation programs.
Quality System Strengthening: Enhancement of quality governance structures, documentation systems, training programs, and compliance monitoring processes.
Regulatory compliance support includes adherence to AEMPS, EU-GMP, PIC/S GMP, and WHO GMP standards. Key activities involve developing Validation Master Plans (VMPs) for various systems and processes, preparing validation protocols, qualification reports, and necessary documentation for inspections. Additionally, inspection readiness programs are implemented through mock inspections and compliance evaluations to ensure preparedness for regulatory audits.
Zenovel leverages engineering and pharmaceutical expertise along with regulatory knowledge to assist organizations in creating and sustaining top-tier manufacturing facilities. Our multidisciplinary strategy guarantees compliance with current regulations while allowing adaptability for future changes.
By enhancing GMP compliance, operational efficiency, and quality infrastructure, Zenovel enables pharmaceutical manufacturers in Spain to mitigate regulatory risks, boost productivity, improve product quality, and ensure long-term readiness for inspections in European and global markets.
Pre-Inspection Readiness Services for GMP Compliance in Spain
Building Inspection Confidence Through Strategic GMP Preparation
Regulatory inspections are vital for pharmaceutical and biotechnology companies, necessitating evidence of compliance and robust quality systems. Zenovel offers Pre-Inspection Readiness Services in Spain, assisting manufacturers in preparing for inspections, identifying compliance gaps, and enhancing our quality and regulatory standing. Our experts collaborate with organizations to assess readiness, implement corrective measures, and ensure conformity with AEMPS, EU GMP standards, PIC/S standards, and international regulations.
Our Pre-Inspection Readiness Services in Spain Include
Comprehensive GMP Gap Assessments: Evaluations of manufacturing operations and quality systems to identify improvement areas prior to inspection.
Mock Regulatory Inspections: Realistic simulations of regulatory inspections utilizing AEMPS, EU-GMP, PIC/S, and international frameworks assess organizational readiness and identify compliance risks.
Data Integrity and CAPA Effectiveness Reviews: Evaluation of controls related to audit trails, computerized systems, deviation management, CAPA programs, and data governance practices to achieve ongoing compliance.
Documentation and Quality System Assessments: Comprehensive review of SOPs, batch manufacturing records, validation documentation, qualification reports, training records, change controls, and the effectiveness of the quality management system.
Inspection Management and Response Planning: Development of comprehensive plans for inspection management, including support procedures, escalation pathways, communication strategies, and response frameworks for regulatory interactions.
Personnel Readiness and Compliance Training: Specialized training programs equip employees for inspections through inspector interview preparation, documentation retrieval practices, effective communication techniques, and clear instruction on inspection-day responsibilities.
Validation and Compliance Readiness Reviews: Evaluation of equipment qualification, process validation, cleaning validation, utility qualification, and computerized system validation programs to ensure inspection preparedness across critical GMP systems.
Zenovel’s GMP inspection readiness solutions assist organizations in proactively addressing compliance issues prior to regulatory inspections. By employing risk-based assessments, tailored remediation plans, and ongoing quality improvement efforts, manufacturers can minimize inspection findings and enhance operational performance.
Our diverse team aids in creating sustainable compliance frameworks that adapt to changing regulatory demands while ensuring operational efficiency and product quality.
Our proactive approach enhances inspection preparedness, contributes to a stronger quality culture, improves compliance performance, and fosters long-term business success in Spain’s regulated pharmaceutical manufacturing sector.
Clinical & Scientific Expert Services in Spain for Innovative Drug Development
Advancing Clinical Development Through Strategic Scientific and Medical Expertise
The development of new therapies requires a robust scientific base, effective clinical strategies, and regulatory planning. Spain has emerged as a key hub for clinical research and pharmaceutical innovation, offering experienced researchers and a supportive regulatory framework.
Zenovel offers specialized Clinical & Scientific Expert Services in Spain to assist organizations in the pharmaceutical, biotechnology, medical device, and healthcare sectors, providing strategic guidance for efficient development programs, meaningful clinical evidence, and navigating regulatory complexities.
Our Clinical & Scientific Expert Services in Spain Include
Clinical Development Strategy and Protocol Design: Development of clinical plans, product profiles, and study protocols that meet the requirements of AEMPS, EMA, ICH guidelines, and global regulatory standards.
Translational Medicine and PK/PD Expertise: Integration of preclinical and clinical data is essential for translational research, guiding dose selection strategies, PK/PD modeling, exposure-response analyses, and informed development decisions.
Biomarker Strategy and Endpoint Development: Identification and evaluation of biomarkers, clinical endpoints, surrogate endpoints, and outcome measures can enhance study efficiency, improve decision-making, and support regulatory acceptance.
Study Design Optimization: Strategic review and optimization of clinical trial designs, focusing on patient populations, inclusion and exclusion criteria, statistical aspects, and operational feasibility to enhance study success.
Therapeutic Area and Medical Consulting: Expert guidance across a broad range of therapeutic areas, including disease understanding, unmet medical needs assessment, clinical relevance evaluation, benefit-risk considerations, and competitive landscape analysis.
Regulatory Science and Development Consulting: Support for interactions with AEMPS, EMA, FDA, and other international health authorities includes scientific and regulatory guidance, development strategy reviews, regulatory meeting preparations, and scientific advice.
Clinical Evidence Generation and Interpretation: Support for evidence generation activities, literature reviews, clinical evaluation strategies, real-world evidence integration, data interpretation, and scientific communication to strengthen development programs.
Benefit-Risk Assessment and Decision Support: Independent scientific evaluation of clinical data to support benefit-risk assessments, development milestones, portfolio decisions, and regulatory submissions.
Zenovel integrates therapeutic expertise with clinical research and regulatory knowledge to assist sponsors in making informed development decisions. By collaborating closely with organizations, Zenovel aims to minimize development risks, enhance scientific justification, and streamline clinical programs from early stages to post-approval. Utilizing a strategic, evidence-based approach, the company optimizes study designs, accelerates development timelines, improves resource use, and boosts the chances of regulatory and commercial success.
Our Clinical & Scientific Expert Services in Spain support organizations in developing strategies, producing quality evidence, and navigating the changing regulatory and healthcare environment in Europe and globally.
Medical & Scientific Writing Services in Spain for Regulatory and Clinical Documentation
Delivering Scientifically Accurate and Regulatory-Compliant Documentation for Successful Product Development
High-quality medical documentation is essential for clinical development, regulatory submissions, and effective communication with health authorities. Zenovel offers Medical & Scientific Writing Services in Spain, assisting pharmaceutical companies, biotechnology firms, medical device manufacturers, CROs, and healthcare institutions. Our experienced writers ensure documents meet AEMPS, EMA, ICH guidelines, and other regulatory standards, supporting informed decision-making and successful product commercialization.
Our Medical & Scientific Writing Services in Spain Include
Clinical Study Reports (CSRs), Protocols, and Investigator Brochures.
Informed Consent Forms and Patient-Facing Materials
CTD and eCTD Documentation Support
Pharmacovigilance and Drug Safety Documentation
Clinical and Regulatory Summaries
Scientific Publications and Medical Communications
Literature Reviews and Evidence Synthesis
Medical Device and Combination Product Documentation
From early clinical development through registration, post-marketing activities, and lifecycle management, Zenovel delivers medical and scientific writing solutions that facilitate efficient regulatory review and effective scientific communication.
Our expertise helps organizations improve document quality, streamline submission processes, reduce regulatory risks, and ensure that critical scientific information is communicated clearly to regulators, investigators, healthcare professionals, and other stakeholders.
Preclinical Support Services in Spain for Early-Stage Drug Development
Advancing Drug Discovery Through Strategic Preclinical Research and Scientific Expertise
A strong preclinical foundation is vital for the successful development of innovative therapies, enabling organizations to assess safety, efficacy, pharmacological properties, and development feasibility before human trials. Strategic preclinical planning minimizes risks and supports regulatory submissions.
Zenovel offers comprehensive Preclinical Support Services in Spain to assist pharmaceutical companies, biotechnology firms, academic institutions, and life sciences innovators, leveraging scientific knowledge and regulatory insight to generate robust evidence for informed development decisions.
Our Preclinical Support Services in Spain Include
In Vitro and In Vivo Study Support: Scientific support encompasses various nonclinical studies, such as toxicology assessments, safety pharmacology evaluations, efficacy studies, pharmacokinetic investigations, pharmacodynamic analyses, and exploratory research programs targeting candidate compounds.
Bioanalytical and Translational Research Services: Integration of laboratory findings with development objectives to support translational medicine strategies, biomarker identification, proof-of-concept activities, and the progression from discovery research to clinical development.
Lead Candidate Evaluation and Optimization: Assessment of compound characteristics, pharmacological profiles, safety considerations, and development potential to support candidate selection and optimization decisions.
ADME and Drug Metabolism Support: Scientific guidance for absorption, distribution, metabolism, and excretion (ADME) studies, helping organizations better understand compound behavior, exposure profiles, and potential development challenges.
Preclinical Development Strategy Consulting: Strategic planning for nonclinical development programs, including study sequencing, development pathway selection, regulatory considerations, and preparation for clinical trial initiation.
Toxicology and Safety Assessment Support: Assistance for toxicology programs is needed to establish the nonclinical safety profile of investigational products, covering areas such as general toxicology, reproductive toxicology, genotoxicity, carcinogenicity, and safety pharmacology.
Biomarker and Translational Science Strategy: Effective biomarker strategies and translational frameworks are essential for interpreting preclinical findings, ultimately supporting evidence-based clinical development planning. .
Regulatory Documentation and Submission Support: Preparation, review, and quality assessment of nonclinical study summaries, investigator brochures, regulatory briefing packages, and related documents in accordance with the standards of Spanish, European, and international regulatory authorities.
Zenovel aids organizations in establishing robust scientific foundations by providing reliable preclinical evidence to inform key development decisions. The multidisciplinary approach merges scientific rigor with regulatory insights, enabling early risk identification and optimization of research strategies.
We offer tailored preclinical support services in Spain to enhance scientific confidence and ensure compliance with global regulatory standards, facilitating successful transitions from laboratory research to clinical development.
Regulatory Affairs & Compliance Services in Spain for Global Market Access
Accelerating Product Registration and Regulatory Success Across European and International Markets
Navigating the complex regulatory environment today requires strategic planning and regulatory expertise. Zenovel offers Regulatory Affairs & Compliance Services in Spain for pharmaceutical, biotechnology, medical device, and healthcare organizations. Our experts assist in developing registration strategies, managing regulatory submissions, and ensuring compliance with AEMPS, EMA, FDA, ICH guidelines, WHO standards, and other global regulatory authorities.
Our Regulatory Affairs & Compliance Services in Spain Include
Regulatory Strategy Development and Gap Analysis: Customized regulatory roadmaps, risk assessments, and gap analyses.
CTD/eCTD Dossier Preparation and Management: Comprehensive support for preparing, compiling, reviewing, and managing CTD and eCTD submissions (Clinical Trial Applications, Investigational New Drug submissions, Marketing Authorization Applications, and related regulatory documentation).
Submission Planning and Regulatory Coordination: Strategic planning and management encompass submission timelines, dossier consistency reviews, authority correspondence, regulatory tracking, and coordination of multidisciplinary submission activities.
Labeling Compliance and Regulatory Intelligence: Review and development of product labeling, prescribing information, package inserts, and regulatory communications.
Lifecycle Management and Post-Approval Support: Support for product renewals, regulatory variations, line extensions, change control activities, commitment management, and ongoing compliance throughout the product lifecycle.
Regulatory Agency Interaction Support: Preparation for scientific advice meetings, regulatory consultations, deficiency responses, health authority queries, and interactions with AEMPS, EMA, FDA, and other regulatory agencies.
Global Registration and Market Expansion Consulting: Strategic guidance for multinational registration programs, international regulatory harmonization, market expansion initiatives, and cross-border product development strategies.
Compliance Monitoring and Regulatory Risk Management: Assessment of regulatory compliance frameworks, identification of submission risks, and implementation of proactive strategies to maintain compliance and support business continuity.
Zenovel offers regulatory affairs expertise to help organizations navigate complex regulatory pathways. Specialists collaborate with teams to ensure compliant and strategic submissions, utilizing knowledge of European and international frameworks to minimize risks and enhance efficiency.
Services support the entire product lifecycle, from early development to marketing authorization, facilitating the introduction of innovative healthcare products in Spain, Europe, and beyond.
Dossier Due Diligence Services in Spain for Regulatory Submission Excellence
Enhancing Regulatory Success Through Comprehensive Dossier Evaluation
Regulatory submissions necessitate precise and complete documentation to ensure timely review and approval by health authorities. Inadequate data can lead to regulatory inquiries and delays. Zenovel offers Dossier Due Diligence Services in Spain, aiding pharmaceutical and healthcare organizations in creating quality submissions through expert assessments of CTD and eCTD dossiers, ensuring compliance with AEMPS, EMA, ICH guidelines, and other global standards.
Our Dossier Due Diligence Services in Spain Include
CTD/eCTD Gap Analysis: Comprehensive review of submission modules to identify missing information, data inconsistencies, unsupported statements, formatting deficiencies, and compliance issues affecting regulatory review.
Clinical, Nonclinical, and CMC Data Assessment: Evaluation of clinical, nonclinical, and Chemistry, Manufacturing, and Controls (CMC) documentation focuses on ensuring scientific consistency, data integrity, and alignment throughout the dossier.
Regulatory Compliance Review: Assessment of dossier content concerning regulatory requirements set by AEMPS, EMA, ICH, FDA, WHO, and other authorities.
Cross-Module Consistency and Integration Review: Evaluation of interrelationships between dossier modules ensures data consistency, accuracy of conclusions, product information, and supporting evidence in the submission package.
Submission Risk Assessment: Identification of potential regulatory concerns, scientific weaknesses, compliance risks, and documentation gaps that may result in agency questions or review delays.
Data Integrity and Traceability Verification: Review of source documentation references, study reports, summaries, and supporting materials to ensure traceability, accuracy, transparency, and consistency across the dossier.
Quality Review and Documentation Enhancement: Scientific and editorial review of dossier content to improve clarity, coherence, regulatory alignment, and overall submission quality.
Regulatory Readiness Evaluation: Comprehensive evaluation of submission readiness, featuring suggestions for corrective measures and risk mitigation strategies before submission to regulatory bodies.
Zenovel’s dossier due diligence services improve submission quality by proactively identifying and resolving potential issues, thus minimizing regulatory deficiencies. Our structured review approach guarantees scientifically credible and compliant packages, streamlining regulatory assessments.
By utilizing scientific expertise and regulatory knowledge, Zenovel supports sponsors in enhancing submission strategies and reducing risks in markets like Spain and Europe, which boosts the chances of successful approvals for regulatory applications.
eCTD Compilation Services in Spain for Global Regulatory Submissions
Delivering High-Quality eCTD Dossiers for Efficient Regulatory Approvals
As global regulatory bodies adopt electronic submission requirements, the creation of electronic Common Technical Document (eCTD) submissions is crucial for product registration and lifecycle management.
Zenovel provides eCTD Compilation Services in Spain, helping pharmaceutical, biotechnology, medical device, and healthcare sectors prepare compliant dossiers that align with AEMPS, EMA, and ICH standards.
Our eCTD Compilation Services in Spain Include
Document Formatting and Module Organization: Preparation and organization of regulatory documents according to CTD and eCTD structures, ensuring consistency, completeness, and compliance across all submission modules.
Hyperlinking, Bookmarking, and Publishing: Creation of technically compliant eCTD submissions through accurate hyperlinking, bookmarking, document navigation, publishing, and dossier assembly in accordance with regulatory specifications.
CTD to eCTD Conversion: Conversion of existing CTD dossiers into fully compliant eCTD formats while maintaining document integrity, traceability, and submission readiness.
Technical Validation and Compliance Review: Execution of validation checks to identify technical issues, formatting inconsistencies, broken links, and publishing errors before regulatory submission.
Lifecycle Management and Sequence Planning: Support for submission lifecycle activities, including sequence management, variations, renewals, responses to regulatory questions, post-approval changes, and maintenance submissions.
Submission Quality Control: Comprehensive quality review of dossiers to verify completeness, technical accuracy, document consistency, and compliance with applicable electronic submission requirements.
Regulatory Publishing Support: Preparation and management of regulatory publishing activities for clinical trial applications, marketing authorization applications, product variations, renewals, and other regulatory submissions.
Global Submission Strategy Support: Assistance with submission planning and dossier preparation for multiple regulatory jurisdictions, ensuring alignment with region-specific electronic submission requirements and expectations.
Zenovel’s eCTD specialists optimize regulatory submission processes by ensuring compliance and technical soundness. Our quality control reduces submission rejections and delays. By combining publishing expertise with regulatory knowledge, Zenovel enhances submission efficiency and communication with health authorities.
We provide customized eCTD compilation services in Spain, supporting submission readiness and regulatory compliance for successful market access both domestically and internationally.
Environmental Risk Assessment (ERA) Services in Spain for Pharmaceutical Compliance and Sustainability
Supporting Sustainable Pharmaceutical Development Through Environmental Risk Assessment Expertise
Environmental sustainability is vital in pharmaceutical development, with regulatory authorities requiring Comprehensive Environmental Risk Assessments (ERAs) to evaluate the environmental impact of medicinal products.
Zenovel provides specialized ERA Services in Spain, helping pharmaceutical and healthcare organizations meet environmental compliance and promote sustainability through expert assessments of the environmental impacts of substances and manufacturing processes.
- Phase I and Phase II Environmental Risk Assessments: Preparation and execution of Phase I and Phase II ERAs
- PEC and PNEC Calculations: Estimation of Predicted Environmental Concentrations (PECs) and Predicted No-Effect Concentrations (PNECs)
- Ecotoxicological Data Assessment: Review and analysis of ecotoxicology studies focus on evaluating potential effects on aquatic organisms, terrestrial ecosystems, and environmental receptors.
- Environmental Impact and Risk Characterization: Evaluates environmental hazards, exposure scenarios, risk factors, and mitigation measures to facilitate informed decision-making and ensure regulatory compliance.
- Manufacturing and Waste Management Assessments: Assessment of environmental aspects in pharmaceutical manufacturing includes analyzing waste streams, wastewater management, emissions control, and sustainability initiatives.
- ERA Documentation and Regulatory Submission Support:Preparation, review, and quality assessment of supporting documentation for regulatory submissions and marketing authorization applications.
- Environmental Risk Mitigation Strategies: The development of effective risk management strategies aims to reduce environmental effects, enhance compliance, and promote sustainable practices in the pharmaceutical industry.
Zenovel helps organizations meet environmental assessment requirements from bodies such as AEMPS, EMA, and FDA. Our experts ensure assessments are scientifically robust and compliant with regulatory standards. By integrating environmental responsibility into pharmaceutical development, Zenovel identifies risks and promotes sustainable solutions.
We offer customized ERA services in Spain throughout the product lifecycle, enhancing compliance and contributing to safer healthcare innovation.
EU QP Support Services in Spain for Batch Release and GMP Compliance
Facilitating Efficient European Market Access Through Expert Qualified Person Support
Qualified Person (QP) certification is crucial for pharmaceutical products in the EU, ensuring compliance with GMP standards and maintaining product quality. Zenovel provides EU QP Support Services in Spain to assist pharmaceutical manufacturers and biotechnology firms with batch certification and regulatory obligations, supporting quality systems and necessary documentation for QP review and certification.
Our EU QP Support Services in Spain Include
- Batch Record Review and GMP Compliance Verification: Assessment of batch manufacturing records, packaging documentation, quality control data, and supporting records.
Deviation Assessment and Quality Impact Evaluation: Review quality risks related to deviations, investigations, out-of-specification results, change controls, and CAPA to facilitate informed decisions on batch disposition.
Qualified Person Coordination and Certification Support: Facilitation of documentation reviews, communication workflows, and quality assessments is essential for supporting QP certification and batch release activities.
Quality Documentation Review: Assessment of certificates of analysis, validation reports, environmental monitoring records, stability data, testing documentation, supplier qualifications, and batch-related quality records.
Regulatory Compliance Verification: Verification of compliance with EU GMP Guidelines, EU GMP Annex 16 requirements, PIC/S GMP standards, and other applicable regulatory expectations governing batch certification and release.
Supply Chain and Manufacturing Oversight Support: Review of manufacturing and supply chain controls to ensure traceability, quality assurance, and compliance throughout the production and distribution process.
Inspection Readiness and Quality Assurance: Support for GMP inspection readiness through quality system evaluations, documentation reviews, mock audits, and compliance assessments that strengthen regulatory preparedness.
Ongoing Quality and Lifecycle Support: Assistance with quality oversight activities, post-approval compliance management, quality risk assessments, and continuous improvement initiatives that support long-term GMP compliance.
Zenovel’s EU QP support specialists assist organizations in establishing efficient and compliant batch release processes by ensuring thorough documentation for QP review. Our structured approach mitigates certification delays and regulatory risks, bolstering confidence in product quality.
By integrating GMP expertise and regulatory knowledge, they help manufacturers maintain efficiency while adhering to European standards. Zenovel aligns with AEMPS, EU GMP Guidelines, and WHO GMP principles, supporting both European and international supply chains to enhance quality oversight and market access.
Regulatory Gap Analysis Services in Spain for Compliance Readiness and Regulatory Excellence
Transforming Compliance Challenges into Sustainable Regulatory Success
In a complex regulatory environment, Zenovel offers Regulatory Gap Analysis Services in Spain for pharmaceutical and healthcare organizations. Our services help to identify compliance gaps to minimize risks, avoid delays, and enhance regulatory readiness. Through detailed evaluations, Zenovel’s experts assess quality systems, regulatory documentation, and processes, supporting sustainable compliance improvements.
Our Regulatory Gap Analysis Services in Spain Include
Dossier Completeness and Data Integrity Reviews: Comprehensive assessment of clinical, nonclinical, and CMC documentation to verify scientific consistency, data integrity, traceability, and compliance with regulatory expectations.
SOP and Quality Management System Assessments: Evaluation of SOPs, QMS, governance frameworks, deviation management processes, CAPA programs, change controls, and compliance monitoring activities.
Regulatory Submission Readiness Evaluations: Review of regulatory dossiers, submission packages, and supporting documentation to assess readiness for submission to the AEMPS, EMA, and other global health authorities.
Gap Identification and Compliance Risk Assessment: Identification of missing information, documentation deficiencies, unsupported claims, process vulnerabilities, regulatory risks, and operational gaps that may affect compliance or regulatory outcomes.
Clinical Research Compliance Reviews: Assessment of clinical trial operations, sponsor oversight activities, monitoring processes, trial documentation, and quality systems against ICH-GCP requirements and applicable clinical research regulations.
Manufacturing and GMP Compliance Assessments: Evaluation of pharmaceutical manufacturing operations, GMP systems, validation programs, quality controls, data integrity practices, and inspection readiness against EU-GMP, PIC/S GMP, WHO GMP, and other applicable standards.
Regulatory Intelligence and Compliance Benchmarking: Comparison of existing practices against current regulatory expectations, industry best practices, and evolving regulatory guidance to identify improvement opportunities.
Remediation Strategy and Corrective Action Planning: Development of prioritized remediation plans, CAPA strategies, implementation roadmaps, and continuous improvement initiatives designed to strengthen compliance and reduce regulatory risk.
Zenovel’s gap analysis methodology aids organizations in proactively identifying compliance issues, thereby preventing regulatory findings. By offering practical recommendations, it enhances quality systems, documentation standards, and process efficiency. Our services align with international regulatory frameworks, supporting compliance for submissions, inspections, and audits, while fostering transparency and continuous improvement throughout the product lifecycle.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
